about
Molecular basis of ligand recognition and transport by glucose transportersLack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndromeCrystal structure of a bacterial homologue of glucose transporters GLUT1-4Glucose Transporter Type I Deficiency (G1D) at 25 (1990-2015): Presumptions, Facts, and the Lives of Persons With This Rare DiseaseGlut1 deficiency (G1D): epilepsy and metabolic dysfunction in a mouse model of the most common human phenotype.The prototypical H+/galactose symporter GalP assembles into functional trimersDeterminants of ligand binding affinity and cooperativity at the GLUT1 endofacial siteA specific pharmacophore model of sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.Functional genomics of membrane transporters in human populations.Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplementThe physiological role of drug transporters.Glucose Galactose Malabsorption complicated with Rickets and Nephrogenic Diabetes Insipidus.Protonation of Glu(135) Facilitates the Outward-to-Inward Structural Transition of Fucose TransporterStructural basis of GLUT1 inhibition by cytoplasmic ATP.Role of monosaccharide transport proteins in carbohydrate assimilation, distribution, metabolism, and homeostasis.Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome.Structural signatures and membrane helix 4 in GLUT1: inferences from human blood-brain glucose transport mutantsA2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrierPredicting the impact of diet and enzymopathies on human small intestinal epithelial cells.The clinical efficacy and safety of sodium glucose cotransporter-2 inhibitors in adults with type 2 diabetes mellitus.GLUT1 deficiency syndrome into adulthood: a follow-up study.Current concepts in the treatment of hereditary ataxias.Targeting of astrocytic glucose metabolism by beta-hydroxybutyrate.Pre- and postprandial electroencephalography in glucose transporter type 1 deficiency syndrome: an illustrative case to discuss the concept of carbohydrate responsiveness.Caffeic acid methyl and ethyl esters exert potential antidiabetic effects on glucose and lipid metabolism in cultured murine insulin-sensitive cells through mechanisms implicating activation of AMPK.Orchestration of the mammalian host cell glucose transporter proteins-1 and 3 by Chlamydia contributes to intracellular growth and infectivity.Functional analysis of the glucose transporters-1a, [corrected] -6, and -13.1 expressed by zebrafish epithelial cells.Renal damage induced by the pesticide methyl parathion in male Wistar rats.Comparative study of expression and activity of glucose transporters between stem cell-derived brain microvascular endothelial cells and hCMEC/D3 cells.Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer's Disease.Isogenic blood-brain barrier models based on patient-derived stem cells display inter-individual differences in cell maturation and functionality.TROSY NMR with a 52 kDa sugar transport protein and the binding of a small-molecule inhibitor.Long-Term Effect of GPi-DBS in a Patient With Generalized Dystonia Due to GLUT1 Deficiency Syndrome.Human Mutations in SLC2A9 (Glut9) Affect Transport Capacity for Urate.
P2860
Q24338453-92F3F10D-3283-41B8-929F-8A5735F2167CQ24613779-EDE82A4B-F812-4F6E-AA65-30B9FA5E494BQ27682874-DF574DF4-3F0D-41FE-B410-3FB71B9CB389Q28082363-B22DDA3D-E3EB-49F8-A4BB-2CA2975B92FAQ30448770-A37538B7-4340-42CC-A305-6E7BFA66C2AAQ33722813-76AD1946-1BA4-4FAA-A715-1CC194BD6030Q33839891-D302047A-06FE-413D-AFE7-679123F1589BQ34084526-DAC742CA-C2C1-43A6-8DE7-E5D12570786CQ34338845-FE944B68-0E34-4EA7-8B7D-29DC0FC5E429Q35223033-A7AE7F1F-DB93-49C3-9E77-411B961A085FQ35563701-9343A99E-C468-4FBA-8275-D6D06334C5DCQ35765121-35BD4600-18F4-4422-B4C3-B858127F1759Q36066960-5F620F71-DFF8-454E-917E-6E86EA5D200EQ36074320-14813639-2597-43BC-A15A-0369808A79C0Q36197966-00233FD0-DB17-4522-8CB9-440024E5F029Q36483148-2F85210E-0BD4-43F8-ADF8-4BAA6D82AE7DQ36711153-951E512C-9279-4D4F-974B-69483555554EQ36867354-10E9A3A2-A02A-454E-8AB7-6011EFD9C532Q36908234-5D0B065C-9425-4286-8226-C171859066EEQ38112660-87F66642-0EC3-4C77-BC9B-D628196E9B69Q38177642-B571B817-FFE7-40A4-94ED-49D5F7672C59Q38799644-4D484CE6-4712-4440-92BD-745269EF062CQ41551604-24480938-0B7D-42A6-B99B-6D9B8598F4FAQ41935925-1FF4503A-2656-4894-A461-4F5801429FB9Q42798128-1D8274D2-A69F-4366-888F-BE923760E74DQ44059073-A55AEEF1-9047-4CAB-999D-868289880961Q47074115-118D8AA2-219E-48EA-9E27-A56A0EF018B2Q47214343-FF6440C7-2B87-4780-8FFD-A38F797E728FQ47675024-F8495245-848E-460C-BD73-72B4234F67C7Q47849388-3ABC65A3-ED86-43B8-A6FF-DC3C33E04FD7Q48292903-FF2FF938-3620-40B2-82A2-D9622FCC7F2CQ54289651-A0CB91DC-ADE8-4357-8BB6-4450BFF6C16BQ55160107-954FD993-1DFF-4394-A7A8-D4BA19A0E165Q55417121-DE06B359-85F0-48F4-A9ED-67C247B0CF5C
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
GLUT1 deficiency and other glucose transporter diseases
@ast
GLUT1 deficiency and other glucose transporter diseases
@en
GLUT1 deficiency and other glucose transporter diseases
@nl
type
label
GLUT1 deficiency and other glucose transporter diseases
@ast
GLUT1 deficiency and other glucose transporter diseases
@en
GLUT1 deficiency and other glucose transporter diseases
@nl
prefLabel
GLUT1 deficiency and other glucose transporter diseases
@ast
GLUT1 deficiency and other glucose transporter diseases
@en
GLUT1 deficiency and other glucose transporter diseases
@nl
P2093
P356
P1476
GLUT1 deficiency and other glucose transporter diseases
@en
P2093
Beatriz Lecumberri
Darryl C De Vivo
Juan M Pascual
P304
P356
10.1530/EJE.0.1500627
P407
P577
2004-05-01T00:00:00Z